Fujifilm Medical Systems has announced that its Synapse PACS medical imaging and information management system has officially received Authority to Operate (ATO) on Department of Defense (DoD) networks in the U.S.
The ATO makes Fujifilm the first company with a networked medical system to gain Risk Management Framework-based ATO.
“This particular ATO is an unprecedented achievement in that our technology had to stand up to the rigors of a brand new risk management framework process recently implemented by the Department of Defense,” said Johann Fernando, chief operating officer at Fujifilm Medical Systems. “The fact that Fujifulm is the very first vendor to meet these new challenges speaks to our unrivaled history of innovation, flexibility and stringent security standards.”
The DoD has transitioned from its traditional DIACAP process to an RMF process within the past year to evaluate technologies and determine ATO status.
Risk Management Framework is a process that combines security and risk management activities in the system development lifecycle. Risk-based approach takes into account effectiveness, efficiency and constraints from laws, directives, executive orders, policies, standards and regulations.
The new ATO is valid until March 2020 and successfully completed a security assessment where the DoD determined that the Synapse PACS line meets RMF controls and the Security and Technical Implementation Guides requirements.
“This latest ATO from the Department of Defense is testimony to the fact that risk mitigation remains a top priority at Fujifilm,” said Bill Lacy, VP of medical informatics at Fujifilm Medical Systems. “We look forward to our continued strong relationship with the DoD.”
[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]
